CA-MIDEA-GROUP
Midea Group, recognized as a leading global technology and innovation enterprise, has successfully completed its 1H 2024 Campus Recruitment Tour with the final event on July 6th at Stanford University. These recruitment activities also represent a significant step in the company's ongoing pursuit of global expansion and the strategic localization of innovation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240709152530/en/
Midea Group's 2024 1H Overseas Campus Recruitment Tour at Stanford University (Photo: Business Wire)
With a diverse portfolio encompassing smart home solutions, industrial technology, building technology, robotics and automation, and innovative businesses, Midea Group has reaffirmed its dedication to global markets through this comprehensive recruitment initiative. Every year, approximately 15-20% of Midea Group's campus recruits have overseas study backgrounds, significantly enriching the company's international talent pool.
Highlights of the 2024 Midea Campus Recruitment:
- Over 3000 candidates participated in the event
- Over 4 countries and 20 engaging campus offline events conducted
- Over 10 specialized roundtables tailored for doctoral candidates
In-Depth Strategic Sessions:
- Leadership Insights: Keynote sessions led by Midea's CTO, CPO, and other executives provided visionary perspectives on the future of technology and Midea's pivotal role.
- Cultural Deep Dive: Emphasizing Midea's people-centric philosophy, the sessions highlighted the company's commitment to employee wellness, benefits, and personal growth.
- Innovation Showcase: Featuring Midea's expansive R&D network, including the Central Research Institute driving the "2+4+N" global R&D strategy, solidifying Midea's leadership in technological innovation.
Interactive and Immersive Experiences:
- Q&A Sessions: Transparent discussions on Midea's values, opportunities, and expectations.
- Roundtable Discussions: In-depth dialogues on R&D initiatives, career growth, and global presence.
- Alumni Sharing: Personal growth stories from alumni provided firsthand insights into career opportunities within Midea.
A Clear Path to Recruitment:
- Overseas Students Exclusive Channel: Overseas students graduating from January 2024 to December 2025 are all our target candidates and are allowed to submit resumes online.
- Process Clarity: Candidates were guided through a transparent application, interview, and job offer process.
- Diverse Opportunities: Roles spanning R&D, AI, IT, engineering, and more showcased Midea's commitment to diverse skill sets and professional interests.
- Global Outlook: With opportunities in over 40 global cities, Midea offered candidates a chance to work in multicultural environments.
Midea's Ongoing Commitment
From the UK to Germany, Japan, and the United States, Midea's 1H 2024 recruitment journey underscores its steadfast commitment to creating an innovative, inclusive, and open-minded platform. The company continues to invest significantly in its people and R&D, ensuring it remains at the forefront of technological advancement.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709152530/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM and Scientek Corporation Sign Reseller Agreement to Boost Quantum Computing in Taiwan18.9.2025 10:11:00 CEST | Press release
Companies aim at fuelling the local quantum ecosystem growth and promote adoption IQM Quantum Computers and Scientek Corporation, a Taiwan-based reseller of scientific instruments and other high-technology products, today announced the signing of a strategic reseller agreement to accelerate the commercialisation of quantum computing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918110284/en/ IQM and Scientek Corporation sign reseller agreement The agreement follows the installation of IQM Spark, the first full-stack superconducting quantum computer at the Taiwan Semiconductor Research Institute (TSRI). Under the reseller agreement, Scientek will sell and promote IQM’s on-premises quantum computers and cloud solutions that meet the evolving needs of universities, research institutions, and enterprises. Combining Scientek's strong market presence and customer-centric approach in Taiwan with IQM’s quantum leadership, the c
Acuity Knowledge Partners Acquires Ascent18.9.2025 09:30:00 CEST | Press release
Acuity Knowledge Partners (Acuity), a leading global provider of bespoke research, data management, analytics and AI solutions to the financial services sector, has announced that it has exchanged on the acquisition of Ascent. The transaction is expected to close on 30th September 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915732380/en/ L-R: Stewart Smythe, Chief Executive Officer, Ascent; Jon O'Donnell, Chief Operating Officer, Acuity Knowledge Partners, and Robert King, Chief Executive Officer, Acuity Knowledge Partners This strategic move significantly expands Acuity's Data and Technology Services (DTS) division and its offering of technology and AI led services and solutions. Ascent, a leading European provider of AI-powered digital transformation services, supports over 170 clients globally, with 550 data, software, and cloud specialists operating across seven European jurisdictions. “Our acquisition of Asc
Shield and PwC UK Forge Strategic Collaboration to Deliver Future-Ready Communications Compliance18.9.2025 08:00:00 CEST | Press release
Collaboration brings together Shield's AI-first platform with PwC's surveillance expertise to deliver measurable compliance outcomes Shield, a leading AI platform for digital communication governance and archiving, today announced a collaboration with PwC UK, one of the world’s most trusted professional services firms. The alliance brings together Shield’s unified, cloud-native solution with PwC’s specialist expertise in communications surveillance delivery, regulatory compliance and complex programme execution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250917394739/en/ Shield and PwC launch a strategic collaboration to modernize eComms surveillance with AI-driven compliance solutions for financial institutions. The collaboration is designed to support institutions as they modernise their approach to communications monitoring, helping them implement an advanced and proactive risk management approach at scale and with co
Almirall Presents Long‑Term Results from First Real‑World Dermatology Study Using WHO‑5 Well‑Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 202518.9.2025 08:00:00 CEST | Press release
Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults with moderate-to-severe psoriasis over two years.POSITIVE is the first real-world evidence (RWE) study in dermatology to use the WHO-5 Well-Being Index as a primary endpoint, complementing traditional measures of skin disease (PASI, PGA), quality of life (DLQI), with the assessment of psychological well-being, marking a paradigm shift towards holistic management of psoriasis.The POSITIVE study highlights Almirall’s leadership in advancing patient-centred dermatology aligned with the WHO’s health definition and recent resolution on skin diseases.Almirall’s extensive scientific contributions to EADV 2025 include 44 abstracts across key dermatological conditions including atopic dermatitis, psoriasis, actinic keratosis, and hidradenitis suppurativa, and two expert-led symposia. Almirall, S.A. (ALM
Curatis: FDA Minutes Confirm Positive Outcome of Meeting on 9. September 2025 – Corticorelin on Track for Phase 318.9.2025 07:00:00 CEST | Press release
Curatis Holding AG (SIX:CURN) received the official minutes from the FDA meeting which took place on 9. September. Based on the totality of the feedback and discussions, Curatis can proceed as planned with the clinical development of corticorelin. Corticorelin is under development as a novel treatment intended to reduce or even eliminate steroid use and associated toxicities thereby potentially impacting the quality of life of patients suffering from peritumoral brain edema (PTBE) associated with metastatic (secondary) brain tumors. The virtual meeting with the FDA provided the opportunity to discuss the clinical development plan for corticorelin and encompassed CMC (Chemistry, Manufacturing and Control), nonclinical and clinical aspects. The offical FDA minutes which Curatis received after publication of the half year results reflect the positive outcome. Curatis may proceed without delay to a regulatory submission supporting a pivotal study in patients suffering from PTBE secondary t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom